朝聚眼科:股東週年大會通告
朝聚眼科:2023年報
Chaoju Eye Care Arms Ink Five Tenancy Deals in Inner Mongolia
Chaoju Eye Care Holdings (HKG:2219) said subsidiaries Baotou City Chaoju Eye Hospital and Chaoju Medical Technology will lease three premises located in China's Inner Mongolia autonomous region from B
Several subsidiaries of Chaoju Ophthalmology (02219) signed separate lease agreements for 5 rental properties
Zhitong Finance App News, Chaoju Ophthalmology (02219) issued an announcement. On April 15, 2024, Baotou Hospital, a subsidiary of the company, signed a lease agreement I with Baotou Chaoju to lease property I for the period from April 15, 2024 to December 31, 2029. On April 15, 2024, Chaoju Medical, a subsidiary of the company, signed a lease agreement II with Baotou Chaoju to lease property II for the period from April 15, 2024 to December 31, 2029. On April 15, 2024, Chaoju Medical and Baotou Chaoju signed a lease agreement III to lease property III.
China Post Securities: Endogenous growth is steady, and the Hong Kong stock healthcare services sector's valuation is highly attractive
Judging from the overall performance of medical service targets in Hong Kong stocks, with the exception of ICL's high revenue base in the early COVID-19 period, where dental revenue was affected by dental implant collection, most of the revenue from other medical service targets increased relatively well.
Chaoju Eye Care Holdings Limited Just Missed EPS By 8.3%: Here's What Analysts Think Will Happen Next
It's been a good week for Chaoju Eye Care Holdings Limited (HKG:2219) shareholders, because the company has just released its latest full-year results, and the shares gained 4.8% to HK$3.93. It
CHAOJU EYE CARE To Go Ex-Dividend On June 12th, 2024 With 0.2208 HKD Dividend Per Share And 0.0767 HKD Special Dividend Per Share
March 27th - $CHAOJU EYE CARE(02219.HK)$ is trading ex-dividend on June 12th, 2024. Shareholders of record on June 13th, 2024 will receive 0.2208 HKD dividend per share and 0.0767 HKD special divi
Changes in Hong Kong stocks | Chaoju Ophthalmology (02219) increased 5% last year's net profit by 21.9% year-on-year, and endogenous epitaxial growth boosted rapid business growth
Chaoju Ophthalmology (02219) increased by 5%. As of press release, it was up 5% to HK$3.99, with a turnover of HK$11.14,900.
Chaoju Ophthalmology (02219.HK)'s annual net profit increased by 20.5% to 220 million yuan
Gelonghui, March 26, 丨 Chaoju Ophthalmology (02219.HK) announced that for the year ended December 31, 2023, the company's revenue increased by 38.3% to RMB 1,369.5 million. The Group's net profit increased by 20.5% to RMB 220.7 million. The Group's non-IFRS adjusted net profit increased 19.8% to RMB 223.1 million. The Board recommended a final dividend of HK$0.2208 per share (2022: HK$0.1738 per share) and a special dividend of HK$0.0767 per share. Number of ophthalmology hospitals operated by the Group from up to
Chaoju Ophthalmology (02219) will pay a special dividend of HK$0.0767 per share on June 28
According to Zhitong Finance App, Chaoju Ophthalmology (02219) announced that the company will pay a special dividend of HK$0.0767 per share on June 28, 2024.
Chaoju Ophthalmology (02219) announced its 2023 annual results. Shareholders should account for profit of 229 million yuan, an increase of 21.9% over the previous year
Chaoju Ophthalmology (02219) announced results for the year ended December 31, 2023, with revenue of 1,369.5 billion...
CHAOJU EYE CARE: (1) ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023; AND (2) UPDATE ON EXPECTED TIMELINE FOR THE USE OF PROCEEDS
Chaoju Eye Care Unit Invests 200 Million Yuan in Bank of China's Structured Deposit Product
A unit of Chaoju Eye Care Holdings (HKG:2219) has subscribed for 200 million yuan of structured deposit products offered by Bank of China (SHA:601988, HKG:3988), a Thursday filing on the Hong Kong bou
Chaoju Ophthalmology (02219.HK): Further subscription for structured deposit products with a total principal amount of 200 million yuan
On March 21, Ge Longhui | Chaoju Ophthalmology (02219.HK) announced that on March 21, 2024, Chaoju Medical Technology (an indirect wholly-owned subsidiary of the company) will further subscribe for Bank of China structured deposit products with a total principal amount of RMB 200 million. The subscription was funded by the Group's surplus cash rather than proceeds from global sales.
Chaoju Ophthalmology (02219.HK) will hold a board meeting on March 26 to approve the annual results
Gelonghui, March 14, 丨 Chaoju Ophthalmology (02219.HK) announced that the company will hold a board meeting on March 26, 2024 to review and approve the annual results and publication of the company and its subsidiaries for the year ended December 31, 2023, and to consider the payment of a final dividend (if any).
CHAOJU EYE CARE: DATE OF BOARD MEETING
Changes in Hong Kong stocks | Chaoju Ophthalmology (02219) is now up more than 5%. The agency says that the company's competitive advantage in Inner Mongolia is clearly sufficient to expand epitaxial
Chaoju Ophthalmology (02219) is now up more than 5%. As of press release, it is up 5.53% to HK$4.01, with a turnover of HK$14.7673 million.
Chaoju Ophthalmology (02219) fell 2.30% and now reports 3.510 yuan, a 52-week low
As of 16:08, Chaoju Ophthalmology (02219) fell 2.30% from yesterday's closing price and is now reporting a 52-week low of $3.510; the trading volume was 11.2 million shares, with a turnover of HK$398,300.
Chaoju Ophthalmology (02219.HK) cancelled 98,500 shares on January 25
Gelonghui, January 25, 丨 Chaoju Ophthalmology (02219.HK) announced the cancellation of 98,500 shares on January 25, 2024.
Chaoju Ophthalmology (02219.HK) spent HK$210,000 to buy back 49,500 shares on January 15
On January 15, Ge Longhui | Chaoju Ophthalmology (02219.HK) announced that on January 15, 2024, it spent HK$210,000 to repurchase 49,500 shares, with a repurchase price of HK$4.24-4.28 per share.
No Data